Company Filing History:
Years Active: 1997-2000
Title: Innovations by Anne H. Galy
Introduction
Anne H. Galy is a prominent inventor based in Palo Alto, California. She has made significant contributions to the field of biomedical research, particularly in the area of hematopoietic cell populations. With a total of four patents to her name, Galy's work has the potential to impact various therapeutic applications.
Latest Patents
Among her latest patents is a method of reconstituting human lymphoid and dendritic cells. This invention relates to methods of enriching hematopoietic cell populations that are enriched in myeloid and/or lymphoid progenitor cells based on cell-specific markers. The methods also provide an enriched population of prethymic lymphoid-committed progenitor cells that lack long-term hematopoietic reconstitution potential. Additionally, compositions enriched for these cells and populations of cells obtained from them are included in the invention. Methods of use for the cells, as well as methods of genetically modifying the cells, are also provided.
Another notable patent involves identifying biological response modifiers involved in similar hematopoietic cell populations. This invention shares similarities with her previous work, focusing on enriching for myeloid and/or lymphoid progenitor cells based on specific markers. The implications of these patents are significant for advancing research in cell therapy and regenerative medicine.
Career Highlights
Anne H. Galy is currently associated with Systemix, Inc., where she continues to innovate and develop her research. Her work has garnered attention in the scientific community, and she is recognized for her contributions to the understanding of hematopoietic cells.
Collaborations
One of her notable collaborators is David DiGiusto, with whom she has worked closely on various projects. Their partnership has led to advancements in the field and has contributed to the success of their research endeavors.
Conclusion
Anne H. Galy's innovative work in the field of hematopoietic cell research showcases her dedication to advancing medical science. Her patents reflect her commitment to improving therapeutic methods and understanding complex biological processes.